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NIH and USDA Funding of Dietary Supplement
Research, 1999–20071
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Abstract
Over one-half of U.S. adults use dietary supplements, so federally supported research into the safety and effectiveness of
these compounds is important for the health of many Americans. Data collected in the Computer Access to Research on
Dietary Supplements database, which compiles federally sponsored dietary supplement-related research, are useful to
scientists in determining the type of dietary supplement research that federal agencies are currently funding and where
research gaps exist. This article describes the dietary supplement-related research funded by the NIH and the USDA.
Between fiscal years 1999 and 2007, the number of research projects and funding for dietary supplement research more
than doubled. During that period, NIH funded 6748 dietary supplement-related projects at a cost of $1.9 billion and the
USDA funded 2258 projects at a cost of $347 million. The top funded dietary supplement ingredient categories were
vitamins andminerals, botanicals, phytochemicals, and fatty acids. Cancer was by far themost frequent health outcome in
dietary supplement research funding, nearly double the next closest health outcome category. Other health outcomes
with the greatest funding were cellular and molecular mechanisms, cardiovascular health, women’s reproductive health,
and immune function. The greatest number of dietary supplement research projects are funded by the NIH National
Cancer Institute, the NIH National Center for Complementary and Alternative Medicine, the NIH Office of Dietary
Supplements, and the USDA Agricultural Research Service. J. Nutr. 141: 1–3, 2011.
Over 53% of participants in the 2003–2006 NHANES
reported using dietary supplements (1) and between 1999 and
2007, dietary supplement sales nearly doubled from $48million to
$94 million (2). The NIH Office of Dietary Supplements (ODS)4
was created to support research on dietary supplements and
disseminate research results. As part of its mission, the ODS
developed the Computer Access to Research on Dietary Supple-
ments (CARDS) database to collect information on federally
funded research projects related to dietary supplements.
The CARDS data are useful to scientists in determining the
type of dietary supplement-related research that agencies are
currently funding and where research gaps exist. The informa-
tion is timely for researchers preparing grant applications,
because it appears ahead of scientific publications, providing
details about research still in progress. As previously described
(3), CARDS can be searched to identify research related to
specific dietary supplement ingredients, health outcomes, and
types of studies. CARDS currently contains projects funded by
the USDA, the Department of Defense, and the institutes and
centers of the NIH beginning with fiscal year (FY) 1999. In FY
2008, the NIH began using a new Research, Condition and
Disease Categorization (RCDC) system to define the 215
categories, including nutrition, that the NIH reports annually
to Congress and the public (4). The RCDC system substantially
changes the way NIH research projects are identified and
therefore makes it difficult to compare the number of nutrition
projects and nutrition spending amounts in FY 2007 and earlier
years with FY 2008 and beyond. This article summarizes the
dietary supplement research portfolio at NIH and USDA prior to
the implementation of the RCDC system. Projects funded by the
Department of Defense comprise a very small percentage of the
data in CARDS and will not be described.
The NIH and the USDA are the largest federal funders of
dietary supplement research. The NIH spent $1.9 billion to fund
6748 projects and the USDA spent $347 million to fund 2258
projects pertaining to dietary supplements from 1999 to 2007.
Overall, the NIH was responsible for 75% of the projects and
84% of the dietary supplement funding categorized in the
CARDS database. The number of NIH projects related to
dietary supplements that were funded each year more than
doubled from 374 in 1999 to over 1039 in 2007. During the
same period, NIH dietary supplement research funding in-
creased nearly 2-fold from $98 million to $278 million. In
contrast, the number of dietary supplement-related projects
supported by the USDA remained essentially flat at ~250/y.
USDA funding, on the other hand, rose for several years, then
dropped below 1999 funding levels in 2005 and did not recover
through 2007. Within the NIH, most institutes and centers had
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some dietary supplement-related research in their portfolio. The
National Cancer Institute supported the most in dietary supple-
ment research ($447 million). The National Center for Com-
plementary and Alternative Medicine was second in dietary
supplement funding ($370 million) followed by the National
Heart, Lung and Blood Institute, National Center for Research
Resources, and the National Institute of Diabetes and Digestive
and Kidney Diseases. Although the ODS does not have direct
funding authority, it spent $65 million cofunding multiple re-
search projects, conferences, and workshops between 1999 and
2007. The largest funder of dietary supplement research within
the USDA ($296 million) was the Agricultural Research Service
followed by the Cooperative State Research, Education and
Extension Service ($51 million).
The level of research funding for various ingredient cate-
gories reflects grant submissions as well as public interest in and
use of various dietary supplement ingredients. Vitamins and
botanicals were the top selling dietary supplements between
1999 and 2007 (5) and this level of public interest was reflected
in federal funding; the most frequently funded dietary supple-
ment ingredient categories at NIH throughout this period were
vitamins and minerals, followed by botanicals, phytochemicals,
fatty acids, and “unspecified” (i.e. topics with no focus on a
particular supplement ingredient, e.g. a training grant or a diet
assessment questionnaire) (Table 1). Substantial changes in
funding may also have occurred in response to scientific findings
with possible public health impact. For example, project funding
in the “hormone” ingredient category more than tripled in
2003–2004 before returning to 1999 levels in 2005. This spike
in alternative hormone replacement therapy research was likely in
response to findings published in 2002 from the Women’s Health
Initiative that raised concerns about the safety of traditional
hormone replacement therapy (6). The top 5 funded dietary
supplement ingredient categories at the USDA were essentially
the same as those at NIH but with “antioxidant” substituted for
“unspecified” as the 5th most-funded category (Table 1).
Cancer, cellular and molecular mechanisms, cardiovascular
disease, women’s reproductive health, and immune function
TABLE 1 Total number of projects and funding for the NIH and USDA top 10 dietary supplement
ingredients in the CARDS database, FY 1999–2007
Ingredient
NIH USDA
Projects, n Funding, USD, millions Projects, n Funding, USD, millions
Vitamins and minerals 3197 1093 1443 294
Botanicals 1583 439 592 87
Phytochemicals 1470 415 697 123
Fatty acids and lipids 1051 304 685 130
Unspecified1 1015 266 81 21
Proteins and amino acids 597 156 229 45
Antioxidants 528 142 290 82
Dietary Fiber and carbohydrates 196 79 165 24
Hormones/precursors 185 57 10 1
Other 196 63 64 9
1 ‘‘Unspecified’’ is a category in which dietary supplements are considered generally with no focus on a particular supplement ingredient,
i.e. a training grant or a diet assessment questionnaire.
TABLE 2 Total number of dietary supplement projects and funding by the NIH and USDA for the top
health outcomes in the CARDS database, FY 1999–20071
Outcome
NIH total funding,
USD, millions
NIH DS2
funding, %
USDA total funding,
USD, millions
USDA DS
funding, %
Cancer 615.0 33 100.5 29
Cardiovascular system 350.2 19 123.5 36
Cellular/molecular mechanisms 350.5 19 59.1 17
Women's reproductive health 260.1 14 32.2 9
Immune function 192.6 10 60.8 18
Musculoskeletal system 164.9 9 60.6 17
Aging 165.4 9 88.8 26
Nutrient requirements and metabolism 88.7 5 123.1 36
Unspecified3 147.0 8 11.4 3
Digestive and gastrointestinal system 105.8 6 24.2 7
Diabetes 81.6 5 40.3 12
Antioxidant function 57.1 3 61.6 18
Pediatrics 57.3 3 53.2 15
Obesity 54.0 3 56.1 16
1 Percentages are calculated using the total number of projects per agency 1999–2007. Percentages total more than 100% because
projects may be included in more than one category.
2 DS, dietary supplement.
3 Project abstract does not describe a specific health outcome being studied.
2 Regan et al. 
 
were the 5 health outcome categories receiving the most dietary
supplement funding from the NIH (Table 2). NIH-funded
dietary supplement research related to cancer outcomes ($615
million) was almost double the next closest health outcome
category ($350 million). Dietary supplement funding related to
cancer increased 300% from 1999 to 2007 and was substan-
tially more than the overall dietary supplement funding increase
of 184%. Funding for cellular and molecular mechanisms
research, a form of basic research, fluctuated through the years,
but also went up ;300% overall from 1999 to 2007. Funding
for both women’s reproductive health and immune function
increased by over 400% and funding for aging-related projects
increased 370%. Diabetes-related dietary supplement funding
experienced a rapid rise, and by FY 2007 funding was over
700% higher than that in 1999. This is undoubtedly a reflection
of diabetes as a growing public health concern.
The focus of USDA-funded dietary supplement research was
similar to that at the NIH but with a somewhat different
emphasis than projects funded by the NIH. The top USDA-
funded health outcome categories were nutrient requirements
and metabolism, cardiovascular system, cancer, aging, and anti-
oxidant function and immune function (tied) (Table 2). USDA
dietary supplement funding by health outcome was essentially
the same ($124 million vs. $123 million) for the top 2 outcomes
and funding for the next 3 outcomes was clustered closely ($60–
100 million).
The type of dietary supplement studies most commonly
funded by the NIH between 1999 and 2007 were human studies
(3267) followed by animal (1796) and in vitro (1498) studies.
Other funding categories were scientific conferences and chemical
analysis. At the USDA, projects were more evenly split between
animal (862) and human (809) studies. The difference in emphasis
between the NIH and USDA reflects the different missions of the 2
agencies: biomedicine vs. food and health-related research.
Forty-five percent of the dietary supplement research sup-
ported by the NIH between 1999 and 2007 was funded via the
Extramural Research Grant (R01) mechanism, with the remain-
der funded primarily via cooperative agreement (U01), General
Clinical Research Centers (M01), Contracts (N01), and Explor-
atory Research grants (R21). In contrast, 62% of USDA dietary
supplement research funding was via Intramural Research (Z01).
Other mechanisms used frequently by the USDA were USDA
Cooperative Agreement (U40), Research Grant (R01), and For-
mula Grant (B10).
CARDS has some limitations due to subjectivity on the part
of agency staff interpreting the definition of dietary supplement
and identifying appropriate projects for inclusion. In addition,
projects in CARDS may be counted multiple times in different
categories, e.g. a project looking at vitamin E and selenium in
cancer and heart disease would be counted once in each supple-
ment category and once in each health outcome category. Despite
these limitations, CARDS provides important insight into federal
funding of dietary supplement research, which is helpful for sci-
entists to determine the type of dietary supplement-related re-
search that agencies are funding and where research gaps exist.
CARDS will continue to capture dietary supplement-related
research funded by the federal government and will expand to
collect data from more federal agencies in the future. The imple-
mentation of RCDC will change the method by which dietary
supplement research information is collected at the NIH and will
have a bearing on the types and numbers of projects identified,
but the full impact of the change in collection method is un-
known at this time. A follow-up publication on the impact of
RCDC on the collection of dietary supplement-related research at
NIH is forthcoming. The CARDS database is publically available
online (7).
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